Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Stefan A. Dyckerhoff sold 197,297 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the sale, the director now owns 6,148 shares of the company’s stock, valued at approximately $556,455.48. This represents a 96.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Astera Labs Stock Up 2.7 %
Shares of ALAB traded up $2.61 during trading hours on Wednesday, reaching $97.79. 5,037,521 shares of the stock traded hands, compared to its average volume of 3,096,189. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $100.09. The company’s 50-day moving average price is $66.06 and its two-hundred day moving average price is $59.22.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The business’s revenue was up 47.1% on a year-over-year basis. On average, sell-side analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.
Institutional Trading of Astera Labs
Wall Street Analyst Weigh In
Several analysts have commented on ALAB shares. JPMorgan Chase & Co. raised their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Morgan Stanley raised their price objective on shares of Astera Labs from $74.00 to $94.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Barclays raised their price objective on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Roth Mkm lifted their target price on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Astera Labs currently has a consensus rating of “Buy” and a consensus target price of $94.67.
Get Our Latest Analysis on ALAB
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More
- Five stocks we like better than Astera Labs
- What is the Shanghai Stock Exchange Composite Index?
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Williams-Sonoma Stock: Buy It and Never Let It Go
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.